Orthopedic Soft Tissue Repair Global Market Report 2024

The orthopedic soft tissue repair market size has grown strongly in recent years. It will grow from $5.61 billion in 2023 to $6.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to factors such as advancements in surgical techniques, technological innovations in implants, an increase in sports-related injuries, the aging population, and ongoing research in regenerative medicine.

The orthopedic soft tissue repair market size is expected to see strong growth in the next few years. It will grow to $8.23 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be attributed to factors such as the increasing geriatric population, a rise in sports injuries, ongoing developments in regenerative medicine, and a growing demand for minimally invasive procedures. Major trends expected in this period include the adoption of biological augmentation techniques, increased demand for minimally invasive procedures, advancements in implant technologies, a focus on tissue engineering, and the development of personalized treatment approaches.

The projected increase in sports-related injuries is poised to drive the growth of the orthopedic soft tissue repair market. These injuries, occurring during sports or exercise, often necessitate orthopedic soft tissue repair to address damage to muscles, blood vessels, fibrous tissue, and other supporting connective tissues. Notably, in 2021, exercise equipment accounted for approximately 409,000 injuries, making it the leading cause of sports-related injuries, as reported by the National Safety Council. Bicycles and accessories ranked second, causing 375,797 injuries in the USA. This trend underscores the growing demand for orthopedic soft tissue repair solutions, fueled by the increasing incidence of sports-related injuries.

The aging global population is anticipated to contribute significantly to the expansion of the orthopedic soft tissue repair market. As individuals aged 65 and older, known as the geriatric population, become more prevalent, there is an increased such aslihood of soft tissue damage, ligament sprains, and tendon injuries. The World Health Organization reports that by 2030, one in six people globally will be 60 or older, with an estimated 2.1 billion individuals in this age group by 2050. Similarly, projections from the UK Parliament's House of Commons Library indicate that by 2043, seniors will constitute 24% of the total UK population, reaching 17.4 million people. The rise in the geriatric population is a significant factor propelling the growth of the orthopedic soft tissue repair market.

Major companies are strategically introducing innovative products, such as the soft tissue stabilization system, to maintain their competitive positions. This medical device aims to support and secure soft tissues such as ligaments or tendons, promoting healing and stability. For example, Paragon 28 Inc., a US-based medical device company, launched the TenoTac 2.0 Soft Tissue Stabilization System in May 2022. This system utilizes a threaded titanium implant with a spiked base to achieve and maintain soft tissue fixation, addressing toe contracture at its source. With a two-handed technique for correction, temporary fixation, and final implant placement, the TenoTac 2.0 Soft Tissue Stabilization System offers a sterile kit with two dorsal lengths to accommodate varying patient anatomies.

Market leaders in orthopedic soft tissue repair are also rolling out new products to enhance their market standing. Paragon 28 Inc. introduced the Grappler Suture Anchor System in May 2022, designed to address challenges in soft tissue tensioning and ligament reconstruction during acute foot and ankle procedures. The system features a drilling wire with a non-skive tip and laser line for safe and accurate drilling. It provides an alternative fixation option to limit implant migration and tension loss during intraoperative tissue reattachment, offering PEEK and titanium anchors for efficiency.

In January 2021, Integra Lifesciences, a US-based medical device company, acquired ACell for $300 million. This strategic acquisition aims to expand Integra Lifesciences' regenerative capabilities, complementing its existing portfolio of orthopedic soft tissue technologies. ACell, a US-based company, specializes in developing and manufacturing unique extracellular matrix products for the repair and remodeling of damaged soft tissues.

Major companies operating in the orthopedic soft tissue repair market report are Arthrex Inc., DePuy Synthes Inc. - Johnson & Johnson, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, CONMED Corporation, Integra LifeSciences Holding Corporation, Smith & Nephew plc, LifeNet Health, Becton Dickinson and Company, MTF Biologics, C.R Bard Inc., Tissue Regenix Group plc, American Medical Systems Inc., Lifecell Corporation, Medtronic plc, Conformis Corporation, DJO Global Inc., Olympus Corporation, Terumo Corporation, Bioventus Inc., Mitek Corporation, Aesculap AG & Co. KG, Braunfels GmbH & Co. KG, OsteoMed Ltd., Healius Ltd., Pacira Pharmaceuticals Inc., Acelera Pharma Ltd., NuVasive Inc., Exactech Inc., Globus Medical Inc.

North America was the largest region in the orthopedic soft tissue repair market in 2023. The regions covered in the orthopedic soft tissue repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic soft tissue repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main procedures associated with orthopedic soft tissue repair include cruciate ligaments repair, rotator cuff repair, lateral epicondylitis treatment, Achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, hip arthroscopy, biceps tenodesis, and others. Cruciate ligament repair is a surgical procedure aimed at replacing the anterior cruciate ligament in the knee with a tissue graft to restore function after an injury. These procedures are performed in various injury locations such as the knee, shoulder, hip, and small joints, with end-users including hospitals, ambulatory centers, and orthopedic clinics.

The orthopedic soft tissue repair market research report is one of a series of new reports that provides orthopedic soft tissue repair market statistics, including orthopedic soft tissue repair industry global market size, regional shares, competitors with an orthopedic soft tissue repair market share, detailed orthopedic soft tissue repair market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic soft tissue repair industry. This orthopedic soft tissue repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.